EnLyte

Manufacturer
Jaymac Pharma | Ocean Healthcare Pvt Ltd
Effective date
2026-09-10
Label type
MEDICAL FOOD
Version
20
Source
daily-update
Hydrated at
2026-09-16 01:01:09

Label at a glance#

ProductEnLyte
Active ingredientLEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL PHOSPHATE ANHYDROUS, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE, BETAINE, CITRIC ACID MONOHYDRATE, SODIUM CITRATE
Label structure10 sections

Dosage and administration

The usual dose is one EnLyte® softgel capsule given daily with or without food, or as directed under medical supervision. No age restrictions. KEEP THIS OUT OF THE REACH OF CHILDREN. Do not exceed the recommended dose.

Storage and handling

Store at controlled room temperature 15°C to 30°C (59°F to 86°F) (See USP). Protect from heat, light and moisture. (Tamper Evident: Do not use if seal is broken or missing.) JAYMAC Pharmaceuticals LLC, 2085 I-49 S. Service Rd, Sunset, LA 70584 MANUFACTURED IN INDIA / PACKAGED IN USA. ​Sept 8 2026 (V12)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

EnLyte®

with DeltaFolate™

[15 mg DFE]

​JAYMAC Pharmaceuticals, LLC

Softgels (30ct bottle)

Medical Food​

​Description

DESCRIPTION SECTION

EnLyte® is a medical food specially formulated for the specific dietary management of patients with inherited defects in methylation-pathway enzymes, including MTHFR, whose impaired conversion of dietary folate to l-methylfolate creates a requirement for l-methylfolate and associated methylation coenzymes, and can result in hyperhomocysteinemia that cannot be met by modification of the normal diet alone. Must be used under the supervision of a licensed practitioner.

Each EnLyte® softgel capsule contains: 50 mcg adenosylcobalamin (vitamin B12) and 15 mg DFE of reduced folates (from 7 mg l-methylfolate magnesium, 2.5 mg folinic acid, and 1 mg folic acid). 

A recent study+ suggested that EnLyte® effectively lowered homocysteine levels in patients positive for the MTHFR (methylenetetrahydrofolate reductase) polymorphism.

+ClinicalTrials.gov identifier: NCT02709668, Correlation of Clinical Response With Homocysteine Reduction During Therapy With Reduced B Vitamins in Patients with MDD Who Are Positive for MTHFR C677T or A1298C Polymorphism.

Ingredients: Olive oil, gelatin, glycerin, magnesium ascorbate, Sharp-PS® Gold (phosphatidylserine-DHA complex), yellow beeswax, purified water, sodium citrate, l-methylfolate magnesium, sunflower lecithin, folinic acid, citric acid, annatto extract, elemental iron (from ferrous glycine cysteinate), folic acid, zinc ascorbate, magnesium l-threonate, natural orange flavor, piperine, CoQ10 (ubidecarenone), betaine, vitamin B12 (adenosylcobalamin), FAD (flavin adenine dinucleotide), NADH (nicotinamide adenosine dinucleotide hydride), vitamin B6 (pyridoxal 5’ phosphate), vitamin B1 (thiamine pyrophosphate).

CONTAINS FISH/KRILL/SOY. No artificial colorants. No dairy, wheat, sugar or egg.

Regulatory: Medical foods are intended for a patient with limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements that cannot be met by the modification of the normal diet alone. This is not an Orange Book product.

INTENDED USE:

INDICATIONS & USAGE SECTION

EnLyte® is intended for patients with inherited defects in methylation-pathway enzymes, including MTHFR, with associated hyperhomocysteinemia, for the specific dietary management of: (1) L-methylfolate and methylation-coenzyme deficiency in patients with major depressive disorder. (2) Impaired folate and B-vitamin coenzyme metabolism, transport, and absorption in patients with attention-deficit/hyperactivity disorder.

EnLyte® may be used with or without medications prescribed for MDD or ADHD.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Allergic reactions have been reported following the use of oral folate. Mild transient diarrhea, itching, transitory exanthema and the feeling of swelling of the entire body has been associated with B12.

​PRECAUTIONS:

PRECAUTIONS SECTION

Folic acid, including reduced forms such as folinic acid, in daily doses above 0.1 mg may obscure the detection of B12 deficiency specifically, the administration of folic acid may reverse the hematological manifestations of B12 deficiency, including pernicious anemia, while not addressing the neurological issues. Folate therapy alone is inadequate for the treatment of a B12 deficiency and must be administered under the supervision of a licensed medical practitioner.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

The usual dose is one EnLyte® softgel capsule given daily with or without food, or as directed under medical supervision. No age restrictions.

KEEP THIS OUT OF THE REACH OF CHILDREN.

Do not exceed the recommended dose.

HOW SUPPLIED:

HOW SUPPLIED SECTION

EnLyte® Bottle of 30, Product Code # 64661-711-30*. EnLyte® is an oval, brownish orange softgel capsule with imprint ENL.

*JayMac Pharmaceuticals does not represent these product codes to be National Drug Codes (NDC). Product codes are formatted according to standard industry practice to meet the formatting requirements of pharmacy and health insurance computer systems.

​STORAGE:

STORAGE AND HANDLING SECTION

Store at controlled room temperature 15°C to 30°C (59°F to 86°F) (See USP).

Protect from heat, light and moisture.

(Tamper Evident: Do not use if seal is broken or missing.)

JAYMAC Pharmaceuticals LLC, 2085 I-49 S. Service Rd, Sunset, LA 70584

MANUFACTURED IN INDIA / PACKAGED IN USA.

​Sept 8 2026 (V12)

WARNING:

WARNINGS SECTION

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 30 SOFTGELS Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130364661711300GTIN-13: 0364661711300
EAN-13: 0364661711300
GTIN-12: 364661711300
UPC-A: 364661711300
GTIN storage (14 digits): 00364661711300
EnLyte Medical Food Label V12 cropped (Sept 8 2026).jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
31adef49-84cb-4c51-b122-69e924e10ea3Product name420240827
df40773e-fe5a-474c-8d32-d19c7094e396Product name220240813
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
cd1aa5b9-18a7-4dc4-8a13-b5c677c859a2Product name120231116
38866763-6a8e-4096-95c3-082a000c243dProduct name120230809
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
d1c9d1af-bddd-448d-86f7-69052b7d5b47Product name120220627
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
7ce39568-aceb-b33a-23ed-c4964cdcf486Product name220210211
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
91c62db0-0295-c81c-d10a-0856c259edd6Product name220200428
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
d32bc2b8-0bb7-2216-87aa-24639646e202Product name320190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
ddff2484-d547-4e6a-bacd-95eef7e31c64Product name220180807
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
90854981-3820-4bc4-a1d3-666ec508941cProduct name220180214
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
6c712ad1-eecf-448f-84d9-5c0c307a7112Product name120161130
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
ebc62596-fc97-4d03-9483-7ba095d25db7Product name120151210
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
64661-711-30EA - Each64661-7119b0ec37f-bfcb-44f2-a05d-e81cec378b2d12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUMACTIVE INGREDIENT6WJM73T46K2
1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUMACTIVE INGREDIENT9ABD9DRK7B2
BETAINEACTIVE INGREDIENT3SCV180C9W2
CITRIC ACID MONOHYDRATEACTIVE INGREDIENT2968PHW8QP2
COBAMAMIDEACTIVE INGREDIENTF0R1QK73KB2
COCARBOXYLASEACTIVE INGREDIENTQ57971654Y2
FERROUS CYSTEINE GLYCINATEACTIVE INGREDIENT8B4OP7RK5N2
FLAVIN ADENINE DINUCLEOTIDEACTIVE INGREDIENTZC44YTI8KK2
FOLIC ACIDACTIVE INGREDIENT935E97BOY82
LEUCOVORINACTIVE INGREDIENTQ573I9DVLP2
LEVOMEFOLATE MAGNESIUMACTIVE INGREDIENT1VZZ62R0812
MAGNESIUM ASCORBATEACTIVE INGREDIENT0N1G6785932
MAGNESIUM L-THREONATEACTIVE INGREDIENT1Y26ZZ0OTM2
NADHACTIVE INGREDIENT4J24DQ09162
PHOSPHATIDYL SERINEACTIVE INGREDIENT394XK0IH402
PYRIDOXAL 5-PHOSPHATEACTIVE INGREDIENTF06SGE49M62
SODIUM CITRATEACTIVE INGREDIENT1Q73Q2JULR2
ZINC ASCORBATEACTIVE INGREDIENT9TI35313XW2
1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINEACTIVE MOIETYDVY07ILF1W2
1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINEACTIVE MOIETYC3019D8IIA2
ANHYDROUS CITRIC ACIDACTIVE MOIETYXF417D3PSL2
ASCORBIC ACIDACTIVE MOIETYPQ6CK8PD0R2
BETAINEACTIVE MOIETY3SCV180C9W2
COBAMAMIDEACTIVE MOIETYF0R1QK73KB2
COCARBOXYLASEACTIVE MOIETYQ57971654Y2
FERROUS CATIONACTIVE MOIETYGW89581OWR2
FLAVIN ADENINE DINUCLEOTIDEACTIVE MOIETYZC44YTI8KK2
FOLIC ACIDACTIVE MOIETY935E97BOY82
LEUCOVORINACTIVE MOIETYQ573I9DVLP2
LEVOMEFOLIC ACIDACTIVE MOIETY8S95DH25XC2
NADHACTIVE MOIETY4J24DQ09162
PHOSPHATIDYL SERINEACTIVE MOIETY394XK0IH402
PYRIDOXAL 5-PHOSPHATEACTIVE MOIETYF06SGE49M62
SODIUM CATIONACTIVE MOIETYLYR4M0NH372
THREONIC ACID, L-ACTIVE MOIETY75B0PMW2JF2
ANNATTOINACTIVE INGREDIENT6PQP1V1B6O2
GELATININACTIVE INGREDIENT2G86QN327L2
GLYCERININACTIVE INGREDIENTPDC6A3C0OX2
LECITHIN, SUNFLOWERINACTIVE INGREDIENT834K0WOS5G2
OLIVE OILINACTIVE INGREDIENT6UYK2W1W1E2
PIPERINEINACTIVE INGREDIENTU71XL721QK2
UBIDECARENONEINACTIVE INGREDIENTEJ27X76M462
WATERINACTIVE INGREDIENT059QF0KO0R2
YELLOW WAXINACTIVE INGREDIENT2ZA36H0S2V2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 37 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64661-71164661-711-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 27 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
192026-01-22full-release2026-06-01 02:52:26
182025-12-08monthly-update2026-06-03 17:47:07

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 133 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
YELLOW WAXYELLOW WAX2ZA36H0S2VTABLET, DELAYED RELEASE / ORAL0.1 mgExact identifier — unii candidate
9 equally ranked IID candidates
GELATINGELATIN2G86QN327LCAPSULE / ORAL10932 mgExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR1 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / NASAL25 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LTABLET, CHEWABLE / ORAL24 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAMUSCULAR15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / AURICULAR (OTIC)63.64 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
YELLOW WAXYELLOW WAX2ZA36H0S2VOINTMENT / TOPICAL20 %w/wExact identifier — unii candidate
9 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET / PERIODONTAL0.53 mgExact identifier — unii candidate
75 equally ranked IID candidates
YELLOW WAXYELLOW WAX2ZA36H0S2VTABLET / ORAL3.22 mgExact identifier — unii candidate
9 equally ranked IID candidates
GELATINGELATIN2G86QN327LTABLET, COATED / ORAL42.12 mgExact identifier — unii candidate
44 equally ranked IID candidates
YELLOW WAXYELLOW WAX2ZA36H0S2VCREAM / TOPICAL5 %w/wExact identifier — unii candidate
9 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, EXTENDED RELEASE / ORAL265 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE / DENTAL20 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGEL / TOPICAL500 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXFILM, EXTENDED RELEASE / BUCCAL34 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGEL / TRANSDERMAL500 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYRUP / ORAL16734 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / VAGINAL227.9 mgExact identifier — unii candidate
75 equally ranked IID candidates
OLIVE OILOLIVE OIL6UYK2W1W1ESOAP / TOPICALNAExact identifier — unii candidate
5 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION, EXTENDED RELEASE / ORAL2000 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE, DENTIFRICE / DENTAL18 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LINJECTION / INTRACAVITARY0.05 mlExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGUM, CHEWING / BUCCAL230 mgExact identifier — unii candidate
75 equally ranked IID candidates
YELLOW WAXYELLOW WAX2ZA36H0S2VTABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
9 equally ranked IID candidates
GELATINGELATIN2G86QN327LSYSTEM / TOPICAL1050 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCLOTH / TOPICAL0.05 mg/mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION/ DROPS / ORAL750 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION, CONCENTRATE / ORAL200 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
YELLOW WAXYELLOW WAX2ZA36H0S2VTABLET, EXTENDED RELEASE / ORAL0.01 mgExact identifier — unii candidate
9 equally ranked IID candidates
GELATINGELATIN2G86QN327LCAPSULE, COATED / ORAL288 mgExact identifier — unii candidate
44 equally ranked IID candidates
OLIVE OILOLIVE OIL6UYK2W1W1ESOLUTION / ORAL425 mg/1mlExact identifier — unii candidate
5 equally ranked IID candidates
GELATINGELATIN2G86QN327LTABLET / SUBLINGUAL19 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXEMULSION / OPHTHALMIC3 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LSOLUTION / INTRAVENOUS34.8 mgExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LCAPSULE / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / ORAL26208 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAVENOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXDROPS / NASAL10 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
OLIVE OILOLIVE OIL6UYK2W1W1ECAPSULE / ORALNAExact identifier — unii candidate
5 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE / ORAL3487 mgExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LGUM, CHEWING / BUCCAL102 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / OPHTHALMIC6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS225 mgExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LPOWDER / RESPIRATORY (INHALATION)100 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXDROPS / ORAL300 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / DENTAL15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRADERMAL1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET / ORAL42 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM / TOPICAL1720 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM, AUGMENTED / TOPICAL55 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOAP / TOPICAL0.76 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii candidate
44 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXELIXIR / ORAL5621 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii candidate
75 equally ranked IID candidates
GELATINGELATIN2G86QN327LINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR14 mgExact identifier — unii candidate
44 equally ranked IID candidates
GELATINGELATIN2G86QN327LELIXIR / ORALNAExact identifier — unii candidate
44 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
eff3383d-a004-4293-b3b9-c10ccb016d23e83b2dd3-a9a0-40bc-ade4-6cd4db433b062022-07-01Boxed warning, Adverse reactionsExact identifier
spl set id: e83b2dd3-a9a0-40bc-ade4-6cd4db433b06

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.